The control group consisted of 128 patients with RA (90% female, mean age 55.9 years old, 85.6% were seropositive (anti-rheumatoid factor (RF) and/or anti-citrullinated protein antibodies (ACPA)). The gene discussed is PRTN3; the disease is rheumatoid arthritis.